Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Time to let AD,PD,ALS platform go to Big Pharma
View:
Post by FarmerBetty on Nov 25, 2022 11:19am

Time to let AD,PD,ALS platform go to Big Pharma

They don't have the resources or expertise to take these into the clinic.
Comment by bball67 on Nov 25, 2022 12:19pm
Let it go sounds like giving it away. Why would they do that. They are on the cusp of a significant revaluation of the stock. Give us all a valuation range for the sale of the Company and it's intellectual property that would be acceptable for you.  500M, 1B, 2B? Give us a number. You won't. Step up or we will consider this just more meaningless chatter. Also, you never answered the ...more  
Comment by FarmerBetty on Nov 25, 2022 1:09pm
You would have to get that valuation from the company, they should know? There presentation quotes " Based on reports for Lecanemab and a Promis 2018 commercial analysis PMN310 opportunity >$1B" There filings indicate a potential combination of drugs for ALS, mentioning Intrabody development would involve a partner with gene therapy expertise. Way out of Promis's league, complex ...more  
Comment by azzymaa on Nov 25, 2022 3:04pm
Bball, just stop it bro. Enough is enough. We all know you have lost a ton of Money with this scam of a company, just cash out that way you can ateast afford to buy dinner. 
Comment by azzymaa on Nov 25, 2022 3:02pm
PMN is a scam and they are misleading investors. People on this forum are so gullible its borderline tarded!
Comment by retiredcop on Nov 25, 2022 5:05pm
Who does?  Your buddy Giovanazzi.. Your group is still very bitter about what happened to him. 
ProMIS Neurosciences Inc